A Review of the Hereditary Component of Triple Negative Breast Cancer: High- and Moderate-Penetrance Breast Cancer Genes, Low-Penetrance Loci, and the Role of Nontraditional Genetic Elements

Journal of Oncology
Darrell L EllsworthRachel E Ellsworth

Abstract

Triple negative breast cancer (TNBC), representing 10-15% of breast tumors diagnosed each year, is a clinically defined subtype of breast cancer associated with poor prognosis. The higher incidence of TNBC in certain populations such as young women and/or women of African ancestry and a unique pathological phenotype shared between TNBC and BRCA1-deficient tumors suggest that TNBC may be inherited through germline mutations. In this article, we describe genes and genetic elements, beyond BRCA1 and BRCA2, which have been associated with increased risk of TNBC. Multigene panel testing has identified high- and moderate-penetrance cancer predisposition genes associated with increased risk for TNBC. Development of large-scale genome-wide SNP assays coupled with genome-wide association studies (GWAS) has led to the discovery of low-penetrance TNBC-associated loci. Next-generation sequencing has identified variants in noncoding RNAs, viral integration sites, and genes in underexplored regions of the human genome that may contribute to the genetic underpinnings of TNBC. Advances in our understanding of the genetics of TNBC are driving improvements in risk assessment and patient management.

References

May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Karin CollettLars A Akslen
Jun 24, 2006·Molecular Cell·Bing XiaDavid M Livingston
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·A N J TuttA Ashworth
Sep 26, 2006·Oncogene·N C Turner, J S Reis-Filho
Oct 10, 2006·Breast Cancer Research and Treatment·Marjan GortNiek S Klazinga
May 29, 2007·Nature·Douglas F EastonBruce A J Ponder
Jun 21, 2007·Breast Cancer Research and Treatment·Robert C MillikanCharles M Perou
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Mar 8, 2008·Breast Cancer Research and Treatment·Mary Jo LundJ William Eley
Sep 17, 2008·Oncogene·Y Yin, W H Shen
Apr 23, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tuomas HeikkinenHeli Nevanlinna
Dec 10, 2009·Nature Biotechnology·Ruiqiang LiJian Wang
Dec 15, 2010·Molecular Oncology·Aleix Prat, Charles M Perou
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Mar 15, 2011·Journal of Mammary Gland Biology and Neoplasia·Ana Cristina VargasSunil R Lakhani
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Jul 23, 2011·Breast Disease·Beth N PeshkinClaudine Isaacs
Aug 17, 2011·Cancer Research·Kristen N StevensFergus J Couch
Feb 15, 2012·Cancer Research·Kristen N StevensFergus J Couch
Aug 14, 2012·International Journal of Cancer. Journal International Du Cancer·Anne DumayHugues de Thé
Oct 27, 2012·Clinical Breast Cancer·Emilia MontagnaMarco Colleoni
Dec 25, 2012·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Jonathan M BernsteinJarrod J Homer
Mar 29, 2013·Nature Genetics·Montserrat Garcia-ClosasPeter Kraft
Jul 5, 2013·International Journal of Cancer. Journal International Du Cancer·Michelle W Wong-BrownRodney J Scott
Jan 7, 2014·Frontiers in Bioscience (Landmark Edition)·Arindam Paul, Soumen Paul
Jun 13, 2014·Journal of Virology·Emanuele MarchiRobert Belshaw
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fergus J CouchPeter A Fasching
Feb 16, 2015·Breast Cancer Research and Treatment·Michelle W Wong-BrownRodney J Scott
Apr 8, 2015·JAMA : the Journal of the American Medical Association·Timothy R RebbeckIrene Andrulis

❮ Previous
Next ❯

Citations

Mar 27, 2020·Medical Sciences : Open Access Journal·Ugo TestaElvira Pelosi
Aug 23, 2020·International Journal of Molecular Sciences·Maria-Ancuta JurjIoana Berindan-Neagoe
Oct 24, 2020·Current Opinion in Obstetrics & Gynecology·Kelly E McCann, Sara A Hurvitz
Feb 9, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Juan JinXichun Hu
May 22, 2021·Curēus·Qasif QaviAbdalla Saad Abdalla Al-Zawi
Apr 27, 2021·British Journal of Pharmacology·Liliana RaimundoLucília Saraiva
Jul 3, 2021·International Journal of Molecular Sciences·Farrukh AqilRamesh C Gupta
Sep 3, 2021·Current Opinion in Oncology·Rinat Bernstein-MolhoShani Paluch-Shimon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

© 2021 Meta ULC. All rights reserved